Detalhe da pesquisa
1.
Estimating the Effect of Tafamidis on Cardiovascular-Related Hospitalization in NYHA Class III Patients with Transthyretin Amyloid Cardiomyopathy in the Presence of Death.
Cardiology;
147(4): 398-405, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35853436
2.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
N Engl J Med;
379(11): 1007-1016, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30145929
3.
Tafamidis for Transthyretin Amyloid Cardiomyopathy.
N Engl J Med;
380(2): 196-197, 2019 01 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30625051
4.
Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimens.
Int J Clin Pharmacol Ther;
52(7): 574-86, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24755127
5.
Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study.
JACC Heart Fail;
12(1): 150-160, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37943223
6.
Effect of Tafamidis on Renal Function in Patients With Transthyretin Amyloid Cardiomyopathy in ATTR-ACT.
JACC CardioOncol;
6(2): 300-306, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38774010
7.
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy.
Eur J Heart Fail;
26(3): 612-615, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38439606
8.
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial.
JAMA Cardiol;
9(1): 25-34, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37966817
9.
Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.
Eur J Heart Fail;
25(11): 2060-2064, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37434378
10.
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary.
Future Cardiol;
19(1): 7-17, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36715498
11.
A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus.
BMC Ophthalmol;
12: 37, 2012 Aug 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22871086
12.
A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloid;
29(4): 228-236, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35730447
13.
Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary.
Future Cardiol;
18(3): 165-172, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34779246
14.
How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary.
Future Cardiol;
2022 03 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35297655
15.
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.
Circ Heart Fail;
15(1): e008193, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34923848
16.
A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.
Ophthalmology;
118(6): 1107-18, 2011 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21529957
17.
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).
Am J Cardiol;
148: 146-150, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33667442
18.
Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
ESC Heart Fail;
8(5): 3875-3884, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34432383
19.
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Am J Cardiol;
141: 98-105, 2021 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33220323
20.
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story.
Drug Des Devel Ther;
15: 1225-1243, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33776421